Control Bionics Limited (CBL.AX)
AUD 0.05
(-1.89%)
AUD 0.05
(-1.89%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 336.16 Thousand AUD | 0.0% |
| 2023 | - AUD | -100.0% |
| 2022 | 124.57 Thousand AUD | 0.0% |
| 2021 | - AUD | -100.0% |
| 2020 | 9000.00 AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | -100.0% |
| 2017 | 32.46 Million NZD | -48.74% |
| 2016 | 63.33 Million NZD | -3.51% |
| 2015 | 65.63 Million NZD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - AUD | 0.0% |
| 2024 Q2 | 46.51 Thousand AUD | 0.0% |
| 2024 Q4 | 336.16 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2024 Q1 | 46.51 Thousand AUD | 0.0% |
| 2023 Q2 | 79.46 Thousand AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 FY | - AUD | -100.0% |
| 2023 Q3 | - AUD | -100.0% |
| 2023 Q1 | 79.46 Thousand AUD | -36.21% |
| 2022 FY | 124.57 Thousand AUD | 0.0% |
| 2022 Q4 | 124.57 Thousand AUD | 0.0% |
| 2022 Q3 | 124.57 Thousand AUD | -31.49% |
| 2022 Q2 | 181.83 Thousand AUD | 0.0% |
| 2022 Q1 | 181.83 Thousand AUD | 0.0% |
| 2021 Q1 | - AUD | -100.0% |
| 2021 FY | - AUD | -100.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 Q4 | 235.73 Thousand AUD | 0.0% |
| 2020 FY | 9000.00 AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 FY | - AUD | -100.0% |
| 2017 FY | 32.46 Million NZD | -48.74% |
| 2017 Q2 | 32.46 Million NZD | 0.0% |
| 2016 FY | 63.33 Million NZD | -3.51% |
| 2015 FY | 65.63 Million NZD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 91.95% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 94.302% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | 78.017% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 99.834% |
| CleanSpace Holdings Limited | 2.76 Million AUD | 87.849% |
| Cyclopharm Limited | 4.01 Million AUD | 91.623% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | 80.969% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 97.297% |
| ImpediMed Limited | 810 Thousand AUD | 58.498% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | 80.713% |
| Micro-X Limited | 65 Thousand AUD | -417.177% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | 54.695% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | 52.591% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 89.579% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |